Cargando…
Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
Human epidermal growth factor receptor 2 (HER2)-amplified breast cancers are treated using targeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor recurrence of metastatic disease. Herein, we conducted gene expression analyses of HER2 kinase inhibitor-res...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808937/ https://www.ncbi.nlm.nih.gov/pubmed/33128042 http://dx.doi.org/10.1038/s41388-020-01530-6 |